Clear cell carcinoma of the ovary: multi-slice computed tomography findings by Xubin Li & Zhaoxiang Ye
WORLD JOURNAL OF 
SURGICAL ONCOLOGY
Li and Ye World Journal of Surgical Oncology  (2015) 13:133 
DOI 10.1186/s12957-015-0546-1RESEARCH Open AccessClear cell carcinoma of the ovary: multi-slice
computed tomography findings
Xubin Li and Zhaoxiang Ye*Abstract
Background: The aim of the study was to describe the multi-slice computed tomography (MSCT) features of clear
cell carcinoma (CCC) of the ovary.
Methods: Twenty patients with histology-confirmed CCC of the ovary were retrospectively reviewed. All patients
underwent preoperative plain and contrast-enhanced MSCT examinations. Imaging studies were evaluated for the
following: (a) location; (b) maximal transverse diameter; (c) shape (round, oval, lobular, or irregular); (d) margin (well
defined or ill defined); (e) solid, solid with cystic regions, or cystic; (f) attenuation of the cystic portion; (g) enhancement
pattern of the solid portions of the tumor; and (h) the secondary manifestations.
Results: The mean age of the patients was 63 years (range, 44 to 77 years). Tumors were unilateral in 19 patients and
bilateral on 1 patient. The maximal transverse diameter of the tumors was relatively larger with a mean diameter of
105.7 mm (range, 45.5 to 260.6 mm). CCCs demonstrated cystic masses with solid regions in 20 lesions. Most lesions
were ovoid (15/21), unilocular (16/21), and well-defined (17/21). The CT value of cystic or necrotic portion ranged from
12 to 28 HU (average, 18 HU) on plain image. The solid protrusions of the cystic masses were both few and round with
obviously heterogeneous enhancements after contrast.
Conclusions: The ovarian CCCs typically present as a large, well-defined, unilocular cystic mass with solid protrusion
and relatively high attenuated cystic or necrotic portions. The solid protrusions are usually both round and few in
number with obviously heterogeneous enhancement.
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Clear cell carcinoma (CCC) of the ovary, a rare histological
subtype of ovarian epithelial carcinoma, is now recognized
as a unique disease with specific developmental origin
activated molecular pathways and clinical features [1].
CCCs are biologically aggressive neoplasms and remarkably
resistant to conventional platinum-based chemotherapy.
However, early-stage CCCs have an excellent prognosis and
may not require any adjuvant therapy [2]. Therefore, pre-
operative accurate diagnosis of CCC may be important for
its optimal therapeutic strategy.
Because of CCC’s low prevalence, previous reports on
imaging findings of ovarian CCCs are few and most reports
focused on magnetic resonance imaging (MRI) [3,4] or* Correspondence: yezhaoxiang@163.com
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multi-slice computed tomography (MSCT) technology
and helical scanning techniques has revolutionized the
use of MSCT for primary diagnostic evaluation of ovar-
ian lesions. The distinct MSCT features of ovarian CCC
have not been well described. Therefore, the objective
of this study was to investigate the MSCT characteris-
tics of ovarian CCC in order to enhance the awareness
of this uncommon entity among both clinicians and
radiologists.Methods
Patients
This retrospective study was approved by the institutional
review boards of our hospital (Tianjin Medical University
Cancer Institute and Hospital, Tianjin, China), wherein
the requirements for informed consent were waived.
Twenty patients with histology-confirmed ovarian CCCis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in this study. All patients underwent plain and contrast
MSCT examinations and then surgical removal of CCCs.
None of the patients underwent biopsy before MSCT
scanning. Their clinical presentations and histological
diagnosis were extracted from the medical records.
MSCT protocols
MSCT scanning was performed by using a LightSpeed
VCT (GE Healthcare, Milwaukee, WI, USA) through the
whole pelvis. The images were acquired with a contiguous
section thickness of 1.25 mm, a field of view of 400 ×
400 mm, a peak voltage of 120 kVp, a tube current of
200 mA, and a matrix of 512 × 512. For contrast-enhanced
imaging, a bolus intravenous dose of 80 ml of nonionic
iodinated contrast agent (Ultravist 300; Schering, Berlin,
Germany) was administered using a power injector
(Multilevel CT; Medrad, Pittsburgh, PA, USA), through
an 18-gauge intravenous catheter placed in the antecubital
vein at a rate of 2.5 ml/s. After the contrast material injec-
tion, 20 ml of normal saline was administered immedi-
ately. The scanning was initiated 60 s after the onset of
contrast injection. The axial images were reconstructed in
both sagittal and coronal planes with a section thickness
of 3 mm.
Image analysis
Two radiologists in gynecologic imaging evaluated all
images retrospectively for a consensus opinion. The fol-
lowing morphologic features were carefully evaluated:
(a) location; (b) maximal transverse diameters; (c) shape
(round, oval, lobular, or irregular); (d) margin (well defined
or ill defined); (e) solid, solid with cystic regions, or cystic;
(f) attenuation of the cystic portion (lowest value mea-
sured in the cystic or necrotic portion of the mass without
enhancement); (g) enhancement pattern of the solid por-
tions of the tumor; and (h) the secondary manifestations
(the involvement of local lymph nodes, adjacent organs,
and ascites). The enhancement patterns of the solid por-
tions were divided into homogeneous and heterogeneous
enhancements.Figure 1 Ovarian clear cell carcinoma in a 49-year-old woman. Axial
oval-shaped mass with smooth margin and irregular solid protrusion (arro
obviously heterogeneous enhancement of the solid component in the tuResults
The patients enrolled in the present study ranged in age
from 44 to 77 years with a mean age of 63 years at diag-
nosis. Fourteen patients were postmenopausal. Seventeen
patients presented with a palpable mass without tender-
ness, while three patients had slight abdominal pain.
Twenty-one lesions of CCC of the ovary were finally
found. CCCs were observed in bilateral ovaries in only
one case. Eleven were on the right and ten were on the
left. In our series, due to our limited awareness of this un-
common tumor, 7 cases were diagnosed as ovarian cysta-
denocarcinoma including bilateral cystadenocarcinomas
in 1 case, and 13 cases were diagnosed as ovarian cystade-
noma before surgery. The maximal transverse diameter of
the tumors ranged from 45.5 to 260.6 mm with a mean
diameter of 105.7 mm.
MSCT imaging of CCCs demonstrated cystic masses
with solid regions in 20 and solid masses in 1. The shape
of the CCCs was found to be round (n = 1), ovoid (n = 15),
lobular (n = 1), or irregular (n = 4), respectively. The mar-
gin was ill-defined in 4 tumors and well-defined in the
remaining tumors. The 20 cystic masses were multilocular
in 4 masses and unilocular in 16 lesions (Figures 1 and 2).
The attenuation of cystic or necrotic portion ranged from
12 to 28 HU (average, 18 HU) on plain MSCT images.
The solid protrusions of the cystic masses were few in
number, round in 15 lesions (Figure 2), and irregular in 5
lesions (Figure 1). The solid components of the CCCs
showed obviously heterogeneous enhancements after con-
trast injection (Figures 1 and 2). The involvements of
local lymph nodes in 2 patients and adjacent organs in
4 patients were identified, which were confirmed by
pathology. Massive or moderate malignant ascites were
found in 7 patients, and minimal benign ascites were
found in 2 patients (Figure 1).
Discussion
CCCs of the ovary are now widely accepted as a unique
disease with specific developmental origin activated mo-
lecular pathways and clinical features. It is a rare subtype
of ovarian carcinomas and accounts for approximatelyprecontrast MSCT image (A) shows a mostly cystic, unilocular, and
w). Axial (B) and sagittal (C) contrast-enhanced CT images show
mor (arrow). Note the minimal fluids (arrowhead).
Figure 2 Ovarian clear cell carcinoma in a 47-year-old woman. Axial precontrast MSCT image (A) shows a mostly cystic, unilocular, and
oval-shaped mass with smooth margin and round solid protrusion (arrow). Axial (B) and sagittal (C) contrast-enhanced CT images show obviously
heterogeneous enhancement of the solid component in the tumor (arrow). The solid protrusions are both round and few in number.
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senting with CCC is approximately 50 years [3]. In the
present study, CCC mainly affected women in the post-
menopausal years (14/20) with a mean age of 63 years and
no distinctive clinical symptoms. The tumors were uni-
lateral in 19 patients (19/20), which was consistent with
the previous reported literature [6]. According to the
literature, distant organ and lymph node involvements
are frequent in patients with recurrent CCC [7]. How-
ever, contrast to the literature, the involvements of local
lymph nodes in 2 patients and adjacent organs in 4 patients
with primary tumors at diagnosis in our cases were
identified.
It is clinically important to differentiate clear cell can-
cer from other ovarian cancers, because the prognosis of
CCC appears to be better than that of other ovarian can-
cers after resection at stage I [8] and MSCT has become
a useful tool to allow local and distant staging of ovarian
cancer in a single examination with the ability of perform-
ing a quick one-stop examination of the whole abdomen
and pelvic. Based on MSCT appearances in our series,
most ovarian CCCs (20/21) showed larger cystic masses
with solid regions. There were 16 lesions demonstrating
a unilocular cystic mass. Most tumors (17/21) had a well-
defined margin. The attenuation of the cystic portion of
the mass was relatively high (average, 18 HU). For the
cystic portion with attenuation higher than 20 HU in 4
lesions, the contents were necrosis or hemorrhage, and
for the cystic portion with attenuation lower than 20 HU,
the content was serous fluid, which was confirmed by
pathology and consistent with the previous report [5].
This is regarded as a differential point from the other
common epithelial origin tumor such as cystadenocarci-
noma, because the cystic content of cystadenocarcinoma
usually has attenuation similar to that of water. For the
solid protrusions of the cystic masses, they were relatively
small in number, round in 15 lesions and irregular in 5
lesions. These findings coincide with the previous re-
port [3]. After contrast, the solid components of the
CCCs showed obviously heterogeneous enhancements,which suggested their hypervascular characteristics. It
indicates, but is not specific for, malignant tumors.
Large peritoneal fluid pockets and peritoneal enhance-
ments are predictive for malignancy [9]. In our series,
massive or moderate malignant ascites were found in 7
patients, and minimal benign ascites were found in 2
patients. Peritoneal lesions were not found by MSCT
before surgery, which was confirmed by pathology after
surgery.
There were some limitations to our study. The main
limitation was that the number of ovarian CCCs that we
assessed was relatively small for the analysis of distinct
MSCT features. Secondly, comparisons with other ovar-
ian neoplasms were not established in our study because
of the low incidence of ovarian CCC. Finally, long-term
follow-up with either MSCT or MRI scans were not well
performed for the patients, and thus, the exact recurrence
and metastasis of ovarian CCC could not be accurately
documented.
Conclusions
Ovarian CCCs typically present as a well-defined, unilocu-
lar cystic mass with solid protrusion and relatively high at-
tenuated cystic or necrotic portions. The solid protrusions
are usually both round and few in number with obviously
heterogeneous enhancements. Although these findings
most likely indicate a CCC of the ovary, the differential
diagnosis should include a serous tumor with low malig-
nant potential or a serous cystadenocarcinoma. Further
research with larger cases is clearly needed for this rare
type of ovarian carcinoma.
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